ctla4 (Bio X Cell)
Bio X Cell is a verified supplier 
Bio X Cell manufactures this product 
96
Structured Review
Bio X Cell
ctla4
Ctla4, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 96/100, based on 409 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+mouse+ctla4+antibody/InVivoMAb+anti-mouse+CTLA-4/10__1080_slash_2162402x__2026__2643494-41-18-25
Average 96 stars, based on 409 article reviews
Ctla4, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 96/100, based on 409 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+mouse+ctla4+antibody/InVivoMAb+anti-mouse+CTLA-4/10__1080_slash_2162402x__2026__2643494-41-18-25
Average 96 stars, based on 409 article reviews
ctla4 - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
other:Article Title: Comparison of the Effectiveness of IgG Antibody versus F(ab′) 2 Antibody Fragment in CTLA4-Targeted Near-Infrared Photoimmunotherapy Article Snippet: An Control:Article Title: Local Depletion of Immune Checkpoint Ligand CTLA4 Expressing Cells in Tumor Beds Enhances Antitumor Host Immunity Article Snippet: A water soluble, silica-phthalocyanine derivative IRDye 700DX NHS ester was obtained from LI-COR Biosciences (Lincoln, NE, USA). .. Injection:Article Title: A novel aptamer-based small RNA delivery platform and its application to cancer therapy. Article Snippet: .. During the treatment period, 100 mg of Article Title: A novel aptamer-based small RNA delivery platform and its application to cancer therapy Article Snippet: .. During the treatment period, 100 μg of Article Title: BRD9 inhibition overcomes oncolytic virus therapy resistance in glioblastoma Article Snippet: IBRD9 (Selleck, #S7835) was dissolved in DMSO (Sigma, #D-2850), diluted in corn oil at 2mg/mL and intraperitoneally administered to mice at the concentration of 16 mg/kg on days 2–4 after tumor injection. .. The anti-mouse PD1 antibody (Bioxcell, #BE0146) and Article Title: BRD9 inhibition overcomes oncolytic virus therapy resistance in glioblastoma. Article Snippet: IBRD9 (Selleck, #S7835) was dissolved in DMSO (Sigma, #D-2850), diluted in corn oil at 2mg/mL and intraperitoneally administered to mice at the concentration of 16 mg/kg on days 2–4 after tumor injection. .. The anti-mouse PD1 antibody (Bioxcell, #BE0146) and Concentration Assay:Article Title: BRD9 inhibition overcomes oncolytic virus therapy resistance in glioblastoma Article Snippet: IBRD9 (Selleck, #S7835) was dissolved in DMSO (Sigma, #D-2850), diluted in corn oil at 2mg/mL and intraperitoneally administered to mice at the concentration of 16 mg/kg on days 2–4 after tumor injection. .. The anti-mouse PD1 antibody (Bioxcell, #BE0146) and Article Title: BRD9 inhibition overcomes oncolytic virus therapy resistance in glioblastoma. Article Snippet: IBRD9 (Selleck, #S7835) was dissolved in DMSO (Sigma, #D-2850), diluted in corn oil at 2mg/mL and intraperitoneally administered to mice at the concentration of 16 mg/kg on days 2–4 after tumor injection. .. The anti-mouse PD1 antibody (Bioxcell, #BE0146) and |